CSE:PREV $0.02

News Releases

Investors
  • 2025
  • 2024
August 20, 2025 BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer
August 19, 2025 BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research
January 7, 2025 BioGene Therapeutics To Participate In The 43RD JP Morgan Healthcare Conference
December 12, 2024 BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board
December 9, 2024 BioGene Therapeutics Appoints Patroski J. Lawson to Board of Directors
December 5, 2024 BioGene Therapeutics Welcomes Ex Pfizer and Moderna Senior Leadership Dr. Barry Ticho.
December 2, 2024 BioGene Therapeutics Welcomes Stephen Glover to Its Board of Directors
November 25, 2024 BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors
November 21, 2024 BioGene Therapeutics Welcomes Professor Mirela Delibegovic, FRSE to Its Scientific Advisory Board
November 18, 2024 PreveCeutical’s subsidary, BioGene Therapeutics Announces Strategic Appointments: Dr. Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer
November 15, 2024 PreveCeutical Announces Closing of BioGene Therapeutics Transaction
November 13, 2024 Preveceutical’s subsidiary, BioGene Therapeutics, appoints President.
October 30, 2024 PreveCeutical Launches Strategic Partnership with BioGene Therapeutics